tradingkey.logo

Allurion rises on plan to offer discounted weight-loss drug Mounjaro in Argentina

ReutersFeb 3, 2026 2:50 PM

Shares of healthcare firm Allurion Technologies ALUR.N rise 6.19% to $1.31

Co says it partnered with Argentine companies Bionut and Farmastar to offer discounted access to Eli Lilly's LLY.N weight-loss pill, Mounjaro, alongside ALUR's swallowable Smart Capsule in Argentina

The Smart Capsule is a tiny pill that can track pH, temperature or gut biomarkers from inside the digestive tract to monitor gut health - co

Co says a study of 76 patients combining low‑dose Mounjaro with its capsule led to 23% average weight loss over one year, with lower side effects and no dropouts

Co says the Smart Capsule is not yet approved in the U.S.; it is exploring similar tie‑ups in other countries

Shares of ALUR fell ~89% in 2025

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI